Chirurgie à visée curative des métastases péritonéales Curative Surgery for Peritoneal Metastases

The complete resection of the peritoneal meta- stases (PM), followed with HIPEC (hyperthermic intraperi- toneal chemotherapy, whose precise therapeutic impact is not yet well-known), allows to obtain numerous cures in eligible patients. This is currently the gold-standard treat- ment when it is possible. Its survival results are strictly simi- lar to those obtained with hepatectomy for liver metastases (LM). The survival rate of the patients with early PM is par- ticularly high, far superior to those of any hepatectomized patient. The main progress will be to early-operate these patients, or to propose a prophylactic approach to those pre- senting a high-risk to develop PM. The concept of second- look surgery + HIPEC is the logical extension of this com- bined approach. In contrast, a non-complete cytoreductive surgery and a large peritoneal extension are contraindica- tions to use this approach.